QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

HOME  |   SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP

This Article Full Text Full Text (PDF) Submit an eLetter Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (194) Citing Articles via Google Scholar Google Scholar Articles by Cao, G. Articles by Chen, J. Search for Related Content PubMed PubMed Citation Articles by Cao, G. Articles by Chen, J.

 Previous Article  |  Next Article 

The Journal of Neuroscience, July 1, 2002, 22(13):5423-5431

In Vivo Delivery of a Bcl-xL Fusion Protein Containing the TAT Protein Transduction Domain Protects against Ischemic Brain Injury and Neuronal Apoptosis

Guodong Cao^{1, 2}, Wei Pei^{1, 2}, Hailiang Ge^{1, 2}, Qinhua Liang^{1, 2}, Yumin Luo^{1, 2}, Frank R. Sharp³, Aigang Lu³, Ruiqiong Ran³, Steven H. Graham^{1, 2, 4}, and Jun Chen^{1, 2, 4}

¹ Department of Neurology and ² Pittsburgh Institute for Neurodegenerative Disorders, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania 15261, ³ Department of Neurology, University of Cincinnati Medical College, Cincinnati, Ohio 45267, and ⁴ Geriatric Research, Educational and Clinical Center, Veterans Affairs Pittsburgh Health Care System, Pittsburgh, Pennsylvania 15261

Bcl-xL is a well characterized death-suppressing molecule of the Bcl-2 family. Bcl-xL is expressed in embryonic and adult neurons of the CNS and may play a critical role in preventing neuronal apoptosis that occurs during brain development or results from diverse pathologic stimuli, including cerebral ischemia. In this study, we used a novel approach to study the potential neuroprotective effect of Bcl-xL as a therapeutic agent in the murine model of focal ischemia/reperfusion. We created a Bcl-xL fusion protein, designated as PTD-HA-Bcl-xL, which contains the protein transduction domain (PTD) derived from the human immunodeficiency TAT protein. We demonstrated that this fusion protein is highly efficient in transducing into primary neurons in cultures and potently inhibited staurosporin-induced neuronal apoptosis. Furthermore, intraperitoneal injection of PTD-HA-Bcl-xL into mice resulted in robust protein transduction in neurons in various brain regions within 1-2 hr, and decreased cerebral infarction (up to ~40%) in a dose-dependent manner, as determined at 3 d after 90 min of focal ischemia. PTD-HA-Bcl-xL was effective even when it was administered after the completion of ischemia (up to 45 min), and the protective effect was independent of the changes in cerebral blood flow or other physiological parameters. Finally, as shown by immunohistochemistry, Western blotting, and substrate-cleavage assays, PTD-HA-Bcl-xL attenuated ischemia-induced caspase-3 activation in ischemic neurons. These results thus confirm the neuroprotective effect of Bcl-xL against ischemic brain injury and provide the first evidence that the PTD can be used to efficiently transduce a biologically active neuroprotectant in experimental cerebral ischemia.

Key words: cerebral ischemia; stroke; protein transduction; Bcl-2; caspase-3, cytochrome c

---

Copyright © 2002 Society for Neuroscience  0270-6474/02/22135423-09$05.00/0

This article has been cited by other articles:

				W.-F. Ma, J. Du, L.-P. Fu, R. Fang, H.-Y. Chen, and S.-H. Cai Phenotypic Knockout of CXCR4 by a Novel Recombinant Protein TAT/54R/KDEL Inhibits Tumors Metastasis Mol. Cancer Res., October 1, 2009; 7(10): 1613 - 1621. [Abstract] [Full Text] [PDF]

				Z. Zhao, C. Park, M. A. McDevitt, C. Glidewell-Kenney, P. Chambon, J. Weiss, J. L. Jameson, and J. E. Levine p21-Activated kinase mediates rapid estradiol-negative feedback actions in the reproductive axis PNAS, April 28, 2009; 106(17): 7221 - 7226. [Abstract] [Full Text] [PDF]

				V. Sebbage Cell-penetrating peptides and their therapeutic applications Bioscience Horizons, March 1, 2009; 2(1): 64 - 72. [Abstract] [Full Text] [PDF]

				A. Valerio, M. Dossena, P. Bertolotti, F. Boroni, I. Sarnico, G. Faraco, A. Chiarugi, A. Frontini, A. Giordano, H.-C. Liou, et al. Leptin Is Induced in the Ischemic Cerebral Cortex and Exerts Neuroprotection Through NF-{kappa}B/c-Rel-Dependent Transcription Stroke, February 1, 2009; 40(2): 610 - 617. [Abstract] [Full Text] [PDF]

				R. A. Stetler, G. Cao, Y. Gao, F. Zhang, S. Wang, Z. Weng, P. Vosler, L. Zhang, A. Signore, S. H. Graham, et al. Hsp27 Protects against Ischemic Brain Injury via Attenuation of a Novel Stress-Response Cascade Upstream of Mitochondrial Cell Death Signaling J. Neurosci., December 3, 2008; 28(49): 13038 - 13055. [Abstract] [Full Text] [PDF]

				Y. Zhou, W. Du, T. Koretsky, G. C. Bagby, and Q. Pang TAT-mediated intracellular delivery of NPM-derived peptide induces apoptosis in leukemic cells and suppresses leukemogenesis in mice Blood, September 15, 2008; 112(6): 2474 - 2483. [Abstract] [Full Text] [PDF]

				F. Sun, Z. Mi, S. B. Condliffe, C. A. Bertrand, X. Gong, X. Lu, R. Zhang, J. D. Latoche, J. M. Pilewski, P. D. Robbins, et al. Chaperone displacement from mutant cystic fibrosis transmembrane conductance regulator restores its function in human airway epithelia FASEB J, September 1, 2008; 22(9): 3255 - 3263. [Abstract] [Full Text] [PDF]

				A. K. Chen, M. A. Behlke, and A. Tsourkas Efficient cytosolic delivery of molecular beacon conjugates and flow cytometric analysis of target RNA Nucleic Acids Res., July 1, 2008; 36(12): e69 - e69. [Abstract] [Full Text] [PDF]

				Z. Li, S. R. McKercher, J. Cui, Z. Nie, W. Soussou, A. J. Roberts, T. Sallmen, J. H. Lipton, M. Talantova, S.-i. Okamoto, et al. Myocyte Enhancer Factor 2C as a Neurogenic and Antiapoptotic Transcription Factor in Murine Embryonic Stem Cells J. Neurosci., June 25, 2008; 28(26): 6557 - 6568. [Abstract] [Full Text] [PDF]

				E. Kondo, T. Tanaka, T. Miyake, T. Ichikawa, M. Hirai, M. Adachi, K. Yoshikawa, K. Ichimura, N. Ohara, A. Moriwaki, et al. Potent synergy of dual antitumor peptides for growth suppression of human glioblastoma cell lines Mol. Cancer Ther., June 1, 2008; 7(6): 1461 - 1471. [Abstract] [Full Text] [PDF]

				J. Du, T. K. Creson, L.-J. Wu, M. Ren, N. A. Gray, C. Falke, Y. Wei, Y. Wang, R. Blumenthal, R. Machado-Vieira, et al. The Role of Hippocampal GluR1 and GluR2 Receptors in Manic-Like Behavior J. Neurosci., January 2, 2008; 28(1): 68 - 79. [Abstract] [Full Text] [PDF]

				M. Hashimoto, M. Taniguchi, S. Yoshino, S. Arai, and K. Sato S Phase-preferential Cre-recombination in Mammalian Cells Revealed by HIV-TAT-PTD-mediated Protein Transduction J. Biochem., January 1, 2008; 143(1): 87 - 95. [Abstract] [Full Text] [PDF]

				B. Murphy, M. Dunleavy, S. Shinoda, C. Schindler, R. Meller, C. Bellver-Estelles, S. Hatazaki, P. Dicker, A. Yamamoto, I. Koegel, et al. Bcl-w Protects Hippocampus during Experimental Status Epilepticus Am. J. Pathol., October 1, 2007; 171(4): 1258 - 1268. [Abstract] [Full Text] [PDF]

				I. P. Koerner, R. Jacks, A. E. DeBarber, D. Koop, P. Mao, D. F. Grant, and N. J. Alkayed Polymorphisms in the Human Soluble Epoxide Hydrolase Gene EPHX2 Linked to Neuronal Survival after Ischemic Injury J. Neurosci., April 25, 2007; 27(17): 4642 - 4649. [Abstract] [Full Text] [PDF]

				A. Antignani and R. J. Youle The Cytokine, Granulocyte-Macrophage Colony-stimulating Factor (GM-CSF), Can Deliver Bcl-XL as an Extracellular Fusion Protein to Protect Cells from Apoptosis and Retain Differentiation Induction J. Biol. Chem., April 13, 2007; 282(15): 11246 - 11254. [Abstract] [Full Text] [PDF]

				E. Dupont, A. Prochiantz, and A. Joliot Identification of a Signal Peptide for Unconventional Secretion J. Biol. Chem., March 23, 2007; 282(12): 8994 - 9000. [Abstract] [Full Text] [PDF]

				I. Inta, S. Paxian, I. Maegele, W. Zhang, M. Pizzi, P. Spano, I. Sarnico, S. Muhammad, O. Herrmann, D. Inta, et al. Bim and Noxa Are Candidates to Mediate the Deleterious Effect of the NF-{kappa}B Subunit RelA in Cerebral Ischemia J. Neurosci., December 13, 2006; 26(50): 12896 - 12903. [Abstract] [Full Text] [PDF]

				R. S. Hotchkiss, K. W. McConnell, K. Bullok, C. G. Davis, K. C. Chang, S. J. Schwulst, J. C. Dunne, G. P. H. Dietz, M. Bahr, J. E. McDunn, et al. TAT-BH4 and TAT-Bcl-xL Peptides Protect against Sepsis-Induced Lymphocyte Apoptosis In Vivo J. Immunol., May 1, 2006; 176(9): 5471 - 5477. [Abstract] [Full Text] [PDF]

				R. W. Mahley, K. H. Weisgraber, and Y. Huang Inaugural Article: Apolipoprotein E4: A causative factor and therapeutic target in neuropathology, including Alzheimer's disease PNAS, April 11, 2006; 103(15): 5644 - 5651. [Abstract] [Full Text] [PDF]

				S. Chang, T. r. Ma, R. D. Miranda, M. E. Balestra, R. W. Mahley, and Y. Huang Lipid- and receptor-binding regions of apolipoprotein E4 fragments act in concert to cause mitochondrial dysfunction and neurotoxicity PNAS, December 20, 2005; 102(51): 18694 - 18699. [Abstract] [Full Text] [PDF]

				F. Bettosini, M. T. Fiorillo, A. Magnacca, L. Leone, M. R. Torrisi, and R. Sorrentino The C Terminus of the Nucleoprotein of Influenza A Virus Delivers Antigens Transduced by Tat to the trans-Golgi Network and Promotes an Efficient Presentation through HLA Class I J. Virol., December 15, 2005; 79(24): 15537 - 15546. [Abstract] [Full Text] [PDF]

				M. Kitazoe, H. Murata, J. Futami, T. Maeda, M. Sakaguchi, M. Miyazaki, M. Kosaka, H. Tada, M. Seno, N.-h. Huh, et al. Protein Transduction Assisted by Polyethylenimine-Cationized Carrier Proteins J. Biochem., June 1, 2005; 137(6): 693 - 701. [Abstract] [Full Text] [PDF]

				B. Albarran, R. To, and P. S. Stayton A TAT-streptavidin fusion protein directs uptake of biotinylated cargo into mammalian cells Protein Eng. Des. Sel., March 1, 2005; 18(3): 147 - 152. [Abstract] [Full Text] [PDF]

				S. Krautwald, E. Ziegler, K. Tiede, R. Pust, and U. Kunzendorf Transduction of the TAT-FLIP Fusion Protein Results in Transient Resistance to Fas-induced Apoptosis in Vivo J. Biol. Chem., October 15, 2004; 279(42): 44005 - 44011. [Abstract] [Full Text] [PDF]

				R. Bright, A. P. Raval, J. M. Dembner, M. A. Perez-Pinzon, G. K. Steinberg, M. A. Yenari, and D. Mochly-Rosen Protein Kinase C {delta} Mediates Cerebral Reperfusion Injury In Vivo J. Neurosci., August 4, 2004; 24(31): 6880 - 6888. [Abstract] [Full Text] [PDF]

				S. Tanaka, K. Kitagawa, S. Sugiura, E. Matsuoka-Omura, T. Sasaki, Y. Yagita, and M. Hori Infiltrating Macrophages as In Vivo Targets for Intravenous Gene Delivery in Cerebral Infarction Stroke, August 1, 2004; 35(8): 1968 - 1973. [Abstract] [Full Text] [PDF]

				Y. Takada, S. Singh, and B. B. Aggarwal Identification of a p65 Peptide That Selectively Inhibits NF-{kappa} B Activation Induced by Various Inflammatory Stimuli and Its Role in Down-regulation of NF-{kappa}B-mediated Gene Expression and Up-regulation of Apoptosis J. Biol. Chem., April 9, 2004; 279(15): 15096 - 15104. [Abstract] [Full Text] [PDF]

				C. J. Farrell, J. M. Lee, E.-C. Shin, M. Cebrat, P. A. Cole, and S. D. Hayward Inhibition of Epstein-Barr virus-induced growth proliferation by a nuclear antigen EBNA2-TAT peptide PNAS, March 30, 2004; 101(13): 4625 - 4630. [Abstract] [Full Text] [PDF]

				X. Zhang, P. Shan, D. Jiang, P. W. Noble, N. G. Abraham, A. Kappas, and P. J. Lee Small Interfering RNA Targeting Heme Oxygenase-1 Enhances Ischemia-Reperfusion-induced Lung Apoptosis J. Biol. Chem., March 12, 2004; 279(11): 10677 - 10684. [Abstract] [Full Text] [PDF]

				K. Nagel-Wolfrum, C. Buerger, I. Wittig, K. Butz, F. Hoppe-Seyler, and B. Groner The Interaction of Specific Peptide Aptamers With the DNA Binding Domain and the Dimerization Domain of the Transcription Factor Stat3 Inhibits Transactivation and Induces Apoptosis in Tumor Cells Mol. Cancer Res., March 1, 2004; 2(3): 170 - 182. [Abstract] [Full Text] [PDF]

				A. Fittipaldi, A. Ferrari, M. Zoppe, C. Arcangeli, V. Pellegrini, F. Beltram, and M. Giacca Cell Membrane Lipid Rafts Mediate Caveolar Endocytosis of HIV-1 Tat Fusion Proteins J. Biol. Chem., September 5, 2003; 278(36): 34141 - 34149. [Abstract] [Full Text] [PDF]

				X. Zhang, P. Shan, J. Alam, R. J. Davis, R. A. Flavell, and P. J. Lee Carbon Monoxide Modulates Fas/Fas Ligand, Caspases, and Bcl-2 Family Proteins via the p38{alpha} Mitogen-activated Protein Kinase Pathway during Ischemia-Reperfusion Lung Injury J. Biol. Chem., June 6, 2003; 278(24): 22061 - 22070. [Abstract] [Full Text] [PDF]

				K. K. Rehman, S. Bertera, R. Bottino, A. N. Balamurugan, J. C. Mai, Z. Mi, M. Trucco, and P. D. Robbins Protection of Islets by in Situ Peptide-mediated Transduction of the Ikappa B Kinase Inhibitor Nemo-binding Domain Peptide J. Biol. Chem., March 7, 2003; 278(11): 9862 - 9868. [Abstract] [Full Text] [PDF]

				J. Vazquez, C. Sun, J. Du, L. Fuentes, C. Sumners, and M. K. Raizada Transduction of a Functional Domain of the AT1 Receptor in Neurons by HIV-Tat PTD Hypertension, March 1, 2003; 41(3): 751 - 756. [Abstract] [Full Text] [PDF]

				S. Asoh, I. Ohsawa, T. Mori, K.-i. Katsura, T. Hiraide, Y. Katayama, M. Kimura, D. Ozaki, K. Yamagata, and S. Ohta Protection against ischemic brain injury by protein therapeutics PNAS, December 24, 2002; 99(26): 17107 - 17112. [Abstract] [Full Text] [PDF]

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help